Organization

Department of Translational Hematology and Oncology Research, Lerner Research Institute

3 abstracts

Abstract
Real life data of KEYNOTE 522: The Cleveland Clinic experience.
Org: Cleveland Clinic Akron General, Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic Moll Cancer Center at Fairview,
Abstract
A population-level analysis of survival in patients with ALK+ anaplastic large cell lymphoma (ALCL) in the era of novel therapies.
Org: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, Department of Translational Hematology and Oncology Research, Lerner Research Institute, Lerner Research Institute,
Abstract
The efficacy of autologous hematopoietic cell transplantation in standard risk multiple myeloma refractory to multiple therapies.
Org: Department of Translational Hematology and Oncology Research, Lerner Research Institute, Lerner Research Institute, Cleveland Clinic Taussig Cancer Instititute, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland, OH, Cleveland Clinic Taussig Cancer Center, Cleveland, OH,